as on October 16, 2025 at 11:40 pm IST
Day's Low
Day's High
0.19%
Downside
7.94%
Upside
52 Week's Low
52 Week's High
14.91%
Downside
48.74%
Upside
Check Legend Biotech Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$6.1B
EPS (TTM)
-0.6079
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-209.0M
Revenue (TTM)
796.8M
Profit Margin
-40.83%
Return On Equity TTM
45379000.00%
Compare market cap, revenue, PE, and other key metrics of Legend Biotech Corp with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $6.1B | 20% | NA | -40.83% | |
BUY | $61.5B | 223.43% | -505.15 | -12.96% | |
NA | $37.1B | NA | NA | -3.89% | |
BUY | $105.7B | 87.04% | 28.99 | 31.86% | |
BUY | $59.6B | -3.89% | 14.07 | 31.37% |
The Legend Biotech Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Legend Biotech Corp investment value today
Current value as on today
₹77,636
Returns
Returns from Legend Biotech Corp Stock
Dollar Returns*
₹4,647 (+4.65%)
Based on 27 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 27 analysts, 88.89% of analysts recommend a 'BUY' rating for Legend Biotech Corp. Average target price of $76
Get share price movements and forecasts by analysts on Legend Biotech Corp.
What analysts predicted
57.72%UPSIDE
Target Price
$76
Current Price
$32.13
Analyzed by
27 Analysts
Target
$76.00
Legend Biotech Corp target price $76, a slight upside of 57.72% compared to current price of $32.13. According to 27 analysts rating.
Search interest for Legend Biotech Corp Stock has increased by 19% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:19% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 14 October
Tue, 05:28 PM
-Legend Biotech reports CARVYKTI® achieved approximately $524 million in Q3 2025 net trade sales, highlighting strong market performance.
Tue, 05:58 PM
-FDA approves label update for CARVYKTI® to include overall survival data, emphasizing serious complications and management needs.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 4 quarters, 160.20M → 255.95M (in $), with an average increase of 14.1% per quarter
Price Rise
In the last 7 days, LEGN stock has moved up by 4.7%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 56.5% return, outperforming this stock by 79.9%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 153.5% return, outperforming this stock by 168.7%
Profit Down
Netprofit is down for the last 3 quarters, 26.28M → -125.82M (in $), with an average decrease of 254.3% per quarter
Organisation | Legend Biotech Corp |
Headquarters | 2101 Cottontail Lane, Somerset, NJ, United States, 08873 |
Industry | Commercial Services |
CEO | Dr. Ying Huang Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Tim Roberts | Global Compliance Officer |
Ms. Elaine Qian | VP & Global Head of Human Resources |
Dr. Mythili Koneru M.D., Ph.D. | Chief Medical Officer |
Mr. Birk Vanderweeen | Senior Vice President of Global Manufacturing & Supply |
Mr. Alan S. Bash | President of CARVYKTI® |
Dr. Ying Huang Ph.D. | CEO & Director |
Ms. Jessie Yeung M.B.A. | Vice President of Finance, Investor & Public Relations |
Mr. James Pepin J.D. | General Counsel |
Dr. Guowei Fang Ph.D. | President of Research & Development |
Mr. Carlos Santos | Chief Financial Officer |
Legend Biotech Corp share price today is $32.13 as on . Legend Biotech Corp share today touched a day high of $34.68 and a low of $32.07.
Legend Biotech Corp share touched a 52 week high of $47.79 on and a 52 week low of $27.34 on . Legend Biotech Corp stock price today i.e. is trending at $32.13,which is 32.77% down from its 52 week high and 17.52% up from its 52 week low.
Legend Biotech Corp market capitalisation is $0.01T as on .
Indian investors can start investing in Legend Biotech Corp (LEGN) shares with as little as ₹87.83 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.30 in Legend Biotech Corp stock (as per the Rupee-Dollar exchange rate as on ).
Based on Legend Biotech Corp share’s latest price of $32.13 as on October 16, 2025 at 11:40 pm IST, you will get 0.3112 shares of Legend Biotech Corp. Learn more about
fractional shares .
Legend Biotech Corp stock has given 20% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?